Background illustration for clinical trials search

Paid Clinical Trials Jersey City

Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects

for
Multiple Sclerosis
Location: Teaneck NJ
Sponsor: Holy Name Medical Center, Inc.

Sex: All

Age: 18+

Code: NCT03424733

Recruiting

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

for
Breast Carcinoma, Colorectal Carcinoma,
Location: Teaneck NJ, Jamaica NY, Englewood NJ, The Bronx NY,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06418204

Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

for
Cardiotoxicity, HER2/Neu Positive,
Location: Teaneck NJ, Summit NJ, Morristown NJ, White Plains NY,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT03418961

Phase 3, Recruiting

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for
Relapsing Multiple Sclerosis
Location: Teaneck NJ, Foxborough MA, Burlington MA, Olney MD,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 40 - 70

Code: NCT06846281

Phase 3, Recruiting

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for
Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer,
Location: Teaneck NJ, Providence RI, Syracuse NY, Fairfax VA,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07024784

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Patient-Specific Simulation Used for EVAR Procedure Rehearsal - Evaluation of Clinical Performance With and Without Prior Rehearsal

for
Infra Renal Aortic Aneurysm
Location: Teaneck NJ, Cleveland OH, Columbus OH, Tampa FL,
Sponsor: Simbionix US Corporation

Sex: All

Age: 18+

Code: NCT02151942

Recruiting

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for
Non-Small Cell Lung Cancer, c-MET
Location: Teaneck NJ, The Bronx NY, Westbury NY,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06568939

Phase 2, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Hackensack NJ, Teaneck NJ, The Bronx NY,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase 2, Phase 3, Recruiting

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

for
Sarcoma
Location: New York NY, Hackensack NJ, Bronx NY, Bethlehem PA,
Sponsor: University of Leicester

Sex: All

Age: 0 - 49

Code: NCT00020566

Phase 3, Recruiting

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

for
Hematologic Malignancies,
Location: Hackensack NJ, Baltimore MD, Boston MA, Chapel Hill NC,
Sponsor: Pulmotect, Inc.

Sex: All

Age: 18+

Code: NCT06665100

Phase 2, Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

for
Hematologic Malignancies, Waldenstroms Macroglobulinaemia,
Location: Hackensack NJ, East Brunswick NJ, Montreal, Ottawa,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04728893

Phase 2, Recruiting

A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Hackensack NJ, Lake Success NY, Charlotte NC,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06697197

Phase 1, Phase 2, Recruiting

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

for
Small Cell Lung Cancer Extensive Stage
Location: Hackensack NJ, Charlottesville VA, Edgewood KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07227597

Phase 1, Phase 2, Recruiting

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

for
Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
Location: New York NY, Ridgewood NJ, Morristown NJ, Eatontown NJ,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT00271180

Recruiting

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for
Breast Neoplasms
Location: Hackensack NJ, Jamaica NY, Westbury NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07060807

Phase 3, Recruiting

Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment

for
Prostate Cancer
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health

Sex: Male

Age: 18+

Code: NCT07011342

Recruiting

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

for
Advanced Solid Tumors, Malignant Neoplasm
Location: Hackensack NJ, Richmond VA, Birmingham AL, Miami FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06818643

Phase 1, Phase 2, Recruiting

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Hackensack NJ, New Brunswick NJ, Philadelphia PA,
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT07096778

Phase 2, Recruiting

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: New Brunswick NJ, New Haven CT, Baltimore MD, Boston MA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06385080

Phase 1, Phase 2, Recruiting

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

for
Cervical Squamous Cell Carcinoma,
Location: Hackensack NJ, New Haven CT, Fairfax VA, Louisville KY,
Sponsor: Alentis Therapeutics AG

Sex: All

Age: 18+

Code: NCT07169734

Phase 1, Phase 2, Recruiting